Anapsos modifies immunological parameters and improves the clinical course in atopic dermatitis.
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003876:Dermatitis, Atopic / Q000188:drug therapy*; D005260:Female; D006027:Glycosides / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011897:Random Allocation
D006027:Glycosides; C006870:anapsos